R-Alpha Lipoic Acid

Alpha-lipoic acid, also called thioctic acid, is an organosulfur compound built around a five-membered dithiolane ring containing two sulfur atoms joined by a disulfide bond ^[1]. The molecule has a single stereocentre, so it can exist as two non-superimposable mirror images, the R and S enantiomers. Only the R enantiomer, written as R-alpha-lipoic acid or RLA, occurs in nature and is the form that living organisms synthesize and use ^[2]. Chemically synthesized lipoic acid, by contrast, is typically a racemate, an equal blend of the R and S forms, because ordinary synthesis produces both ^[1][2]. Studies indicate that these forms are not equivalent, with the natural R enantiomer generally regarded as the more active and better absorbed ^[1][2].

In its natural setting, R-alpha-lipoic acid is bound to proteins and serves as an essential cofactor for several key enzyme complexes inside mitochondria, the cell's energy factories ^[1]. It is required by the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes, which feed the citric acid cycle, as well as by other complexes involved in amino acid breakdown ^[1]. Attached to these enzymes, it shuttles chemical groups and electrons during the reactions that release energy from food. This central metabolic role, combined with its capacity to take part in oxidation and reduction reactions, is the foundation of the compound's biological importance ^[1].

Interest in lipoic acid as a supplement and medicine stems largely from its antioxidant behaviour and its use in diabetic complications ^[1]. The best-supported clinical use is diabetic peripheral neuropathy, the nerve damage that can accompany diabetes: in Germany, alpha-lipoic acid has been licensed as a treatment for this condition for decades, and a meta-analysis of several randomized trials found that giving it by infusion over a few weeks safely improved neuropathic symptoms such as pain, burning, and numbness to a clinically meaningful degree ^[1][3]. Lipoic acid has also been studied for a range of other conditions, including obesity and central nervous system disorders, but the evidence there is of more limited quality ^[1]. A recurring theme in the research is that lipoic acid's usefulness is constrained by its pharmacokinetics; taken by mouth it has only moderate bioavailability, a short half-life, and instability in the stomach, and the R enantiomer, particularly in specialized liquid formulations, shows better absorption than the racemic or solid forms ^[1][2].

R-alpha-lipoic acid and racemic alpha-lipoic acid are widely sold as dietary supplements, in capsules, tablets, and liquids, with the R form often marketed as the superior version ^[2]. Because naturally occurring lipoic acid is tightly bound within foods and hard to extract in useful amounts, the material used in supplements is chemically synthesized ^[1]. Its regulatory standing varies by country: it is a nonprescription supplement in many places and, in Germany, an approved drug for diabetic neuropathy, while broader therapeutic claims remain unproven ^[1].

Generally well tolerated; sides include GI upset and, because it lowers blood sugar, potential hypoglycemia especially alongside diabetes medications. Rare reports of a rash or, at very high doses, an autoimmune insulin syndrome exist. R-ALA is less stable than racemic ALA, so quality and stabilization matter.